19-hydroxyprostaglandin H2

(5Z)-7-{(1R,4S,5R,6R)-6-[(1E,3S)-3,7-dihydroxyoct-1-en-1-yl]-2,3-dioxabicyclo[2.2.1]hept-5-yl}hept-5-enoic acid

MTVPUJQVDLAVML-AHYYGCRPSA-N CHEBI:63912 5 Reactome links 1 studies

1 Observed studies

1 Observed diff profiles

5 Reactome pathways

Metabolite details

Identifier: MTVPUJQVDLAVML-AHYYGCRPSA-N
InChI Key: MTVPUJQVDLAVML-AHYYGCRPSA-N
IUPAC name: (5Z)-7-{(1R,4S,5R,6R)-6-[(1E,3S)-3,7-dihydroxyoct-1-en-1-yl]-2,3-dioxabicyclo[2.2.1]hept-5-yl}hept-5-enoic acid
Preferred name: 19-hydroxyprostaglandin H2
INN name: —
Synonym: (5Z,13E,15S)-9α,11α-epidioxy-15,19-dihydroxyprosta-5,13-dienoic acid
ChEBI: CHEBI:63912

Reactome pathways

R-HSA-1430728 - Metabolism
R-HSA-211859 - Biological oxidations
R-HSA-211897 - Cytochrome P450 - arranged by substrate type
R-HSA-211945 - Phase I - Functionalization of compounds
R-HSA-211979 - Eicosanoids

Observed in studies

Metabolic Dynamics of In Vitro CD8+ T Cell Activation.

Observed in differential profiles

G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h